{"ticker": {"uuid": "781dd906-2ac9-4aeb-bfc3-6eabd524d24b", "symbol": "4592", "name": "SanBio Company Limited", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Price to sales forward of SanBio Co., Ltd. \u2013 TSE:4592", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQQUpTZmxqZHlrM0VNblZxU2czdGd3U0FCYzhBS19DUHlxa0puVHRNLUpvQWdRSXhvejlhOTlMMldaMkNwVVNxRm5oaEJMWXM0LU9yWnVuMXhkSXBoVXF1TE9lWGFRUFhZd2Fycm1rSXZEN3ZFZzlFYXE1QmlLSWNWT3NmYjlTWWdHamtscDh5TUlxT0xoa05JZnhB?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T21:59:53+00:00", "published_display": "09 Jul 2026 21:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SanBio Company: AKUUGO\u00ae commercial launch in Japan and improved quarterly net loss highlight the period", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgJBVV95cUxNcnpXbnVZMFBiMmZoRjlNZXZYR01qOFhLMzdTRE9fV1ZWU3VmRmk0TUFtRkV6NF9adGJNWDVSQ0JhOWhSYV96U0tzVXRORGdkdWxxMkpLeUtQN0VZYVJhUldiWHJ0RnZwcDhJMFhwTU5Ka1VMWHVLakozT3BucnduSjZBS2V1Q2FsZldxWWY1eG5Za2ZmMU1fTktpbWtQY1VMc1hZYlZuLVI1WlBZWXpjNjBMSUdPdThpd2Q3RDhwSGw2WVcxNmxIaWpiNlVoZC1sN3dnZG5Kd1ZkeDJMQmI4WHNXeXBNV1o0R1FXdDBQUWhoVHpmMWJPSS0weXpoaktKUkxSeXAtQmxEZS05eEdSemp3?oc=5", "source_name": "TradingView", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SanBio Q2 2026 slides reveal increased R&D spending, FDA agreement on Phase 3 trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPaFZYRUtTME04NEJHTEo0T1g4enpKcVlJNHRBTnBsbDA2OEJEN2tkMFc4RExndy1iRWY4cEEwZ3p6eVd6R251WGR1UWZBejZHdHN0MHVYWFZ1ek5RNXlfanlEYmNPaTNCbk9RMWp1RjFYdjd2TXFtcmNxdHlvd18wWm1EMEk3QkNWTFFoaWhoMk9kMnUteFNmSmxxMG5OQlJjSWNQRVh6MDRCRzR4V3FuRmx1ellwMUtuT3VZdUEtU3otTkZDVk0zU2JoX0YzaXJ5VVJwNQ?oc=5", "source_name": "Investing.com", "published_at": "2025-10-03T07:00:00+00:00", "published_display": "03 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to sales forward of SanBio Co., Ltd. \u2013 TSE:4592", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQQUpTZmxqZHlrM0VNblZxU2czdGd3U0FCYzhBS19DUHlxa0puVHRNLUpvQWdRSXhvejlhOTlMMldaMkNwVVNxRm5oaEJMWXM0LU9yWnVuMXhkSXBoVXF1TE9lWGFRUFhZd2Fycm1rSXZEN3ZFZzlFYXE1QmlLSWNWT3NmYjlTWWdHamtscDh5TUlxT0xoa05JZnhB?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T21:59:53+00:00", "published_display": "09 Jul 2026 21:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SanBio Company: AKUUGO\u00ae commercial launch in Japan and improved quarterly net loss highlight the period", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgJBVV95cUxNcnpXbnVZMFBiMmZoRjlNZXZYR01qOFhLMzdTRE9fV1ZWU3VmRmk0TUFtRkV6NF9adGJNWDVSQ0JhOWhSYV96U0tzVXRORGdkdWxxMkpLeUtQN0VZYVJhUldiWHJ0RnZwcDhJMFhwTU5Ka1VMWHVLakozT3BucnduSjZBS2V1Q2FsZldxWWY1eG5Za2ZmMU1fTktpbWtQY1VMc1hZYlZuLVI1WlBZWXpjNjBMSUdPdThpd2Q3RDhwSGw2WVcxNmxIaWpiNlVoZC1sN3dnZG5Kd1ZkeDJMQmI4WHNXeXBNV1o0R1FXdDBQUWhoVHpmMWJPSS0weXpoaktKUkxSeXAtQmxEZS05eEdSemp3?oc=5", "source_name": "TradingView", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SanBio Q2 2026 slides reveal increased R&D spending, FDA agreement on Phase 3 trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPaFZYRUtTME04NEJHTEo0T1g4enpKcVlJNHRBTnBsbDA2OEJEN2tkMFc4RExndy1iRWY4cEEwZ3p6eVd6R251WGR1UWZBejZHdHN0MHVYWFZ1ek5RNXlfanlEYmNPaTNCbk9RMWp1RjFYdjd2TXFtcmNxdHlvd18wWm1EMEk3QkNWTFFoaWhoMk9kMnUteFNmSmxxMG5OQlJjSWNQRVh6MDRCRzR4V3FuRmx1ellwMUtuT3VZdUEtU3otTkZDVk0zU2JoX0YzaXJ5VVJwNQ?oc=5", "source_name": "Investing.com", "published_at": "2025-10-03T07:00:00+00:00", "published_display": "03 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 2, "score": 45, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 989.0, "latest_week": "2026-07-10", "one_week_move": -7.8, "four_week_move": -17.7, "twelve_week_move": -52.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.170756, "market_dynamics_buy_signal": false, "relative_strength": -64.615205, "fair_value_gap": -27.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 49.1492, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.8% over one week, -17.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "Investing.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "45/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-7.8% over one week, -17.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to sales forward of SanBio Co., Ltd. \u2013 TSE:4592"}], "updated_at": "2026-07-17T16:59:35.318760+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}